The Novel Conjugates Summit is dedicated to advancing next-generation conjugate therapeutics, including ADCs, by focusing on innovative drug delivery, linker technology, and optimized therapeutic targeting. It brings together experts from biopharma, biotech, and academia to share insights and foster collaboration.
